Current Neuro-Oncology
Volume
26 Number 26
20 November 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 26, 20 November
Cozzens JW, Lokaitis BC, Delfino K, Hoeft A, Moore BE, Fifer AS,
Amin DV, Espinosa JA, Jones BA, Acakpo-Satchivi L.
A
Phase 2 Sensitivity and Selectivity Study of High-Dose
5-Aminolevulinic Acid in Adult Patients Undergoing Resection of a
Newly Diagnosed or Recurrent Glioblastoma.
Oper
Neurosurg (Hagerstown). 2024 Nov 11. doi:
10.1227/ons.0000000000001417. PMID:
39526779. Interventional study˰
ˍ
*El-Hajj VG, Ranganathan S, Hoang H, Ghaith AK, Bydon M,
Elmi-Terander A.
The impact of
adjuvant radiotherapy on overall survival in spinal low-grade
gliomas: a propensity score-matched analysis.
J
Neurooncol. 2024 Nov 11. doi:
10.1007/s11060-024-04880-3. PMID:
39527384. Observational study. ˍ
Gdynia HJ, Schneiderat P, Gratzer A, Wiedhopf K, Gdynia N, Haase
I.
Clinical features and
rehabilitation outcome after surgical treatment of spinal
meningioma.
Spinal
Cord Ser Cases. 2024 Nov 11;10(1):75. doi:
10.1038/s41394-024-00688-5. PMID:
39528486. Observational study˰
ˍ
Kanamori M, Shibahara I, Shimoda Y, Akiyama Y, Beppu T, Ohba S,
Enomoto T, Ono T, Mitobe Y, Hanihara M, Mineharu Y, Ishida J,
Asano K, Yoshida Y, Natsumeda M, Nomura S, Abe T, Yonezawa H,
Katakura R, Shibui S, Kuroiwa T, Suzuki H, Takei H, Matsushita H,
Saito R, Arakawa Y, Sonoda Y, Hirose Y, Kumabe T, Yamaguchi T,
Endo H, Tominaga T.
Efficacy and
safety of carmustine wafers, followed by radiation, temozolomide,
and bevacizumab therapy, for newly diagnosed glioblastoma with
maximal resection.
Int
J Clin Oncol. 2024 Nov 11. doi:
10.1007/s10147-024-02650-9. PMID:
39527165. Interventional study.
ˍ
*Puranik AD, Dev ID, Rangarajan V, Jain Y, Patra S, Purandare NC,
Sahu A, Choudhary A, Bhattacharya K, Gupta T, Chatterjee A,
Dasgupta A, Moiyadi A, Shetty P, Singh V, Sridhar E, Sahay A, Shah
A, Menon N, Ghosh S, Choudhury S, Shah S, Agrawal A,
Lakshminarayanan N, Kumar A, Gopalakrishna A.
FET
PET to differentiate between post-treatment changes and recurrence
in high-grade gliomas: a single center multidisciplinary clinic
controlled study.
Neuroradiology.
2024 Nov 11. doi:
10.1007/s00234-024-03495-9. PMID:
39527264. Observational study. ˍ
*Wee CW, Lee JH, Lee HI, Kim J, Chang JH, Kang SG, Kim EH, Moon
JH, Cho J, Park CK, Kim CY, Hwang K, Yoon HI, Kim IA.
To
Use or Not to Use: Temozolomide in Elderly Patients with IDH
Wild-type MGMT Promoter Unmethylated Glioblastoma Treated with
Radiotherapy.
Cancer
Res Treat. 2024 Nov 11. doi:
10.4143/crt.2024.945. PMID:
39529389. Observational study. ˍ
Johnstad C, Reinertsen I, Thurin E, Dunås T, Bouget D,
Sagberg LM, Jakola AS, Solheim O.
The
prognostic importance of glioblastoma size and shape.
Acta
Neurochir (Wien). 2024 Nov 12;166(1):450. doi:
10.1007/s00701-024-06351-0. PMID:
39531176. Observational study. ˍ
Berghaus N, Hielscher T, Savran D,
Schrimpf D, Maas SLN, Preusser M, Weller M, Acker T, Herold-Mende
C, Wick W, von Deimling A, Sahm F.
Meningiomas:
Sex-Specific Differences and Prognostic Implications of a
Chromosome X Loss.
Neuro
Oncol. 2024 Nov
13:noae239. doi:
10.1093/neuonc/noae239. PMID:
39535060. Observational study; Laboratory investigation˰
ˍ
Bonaventure A, Simpson J, Kane E, Roman E.
Maternal
illnesses during pregnancy and the risk of childhood cancer: A
medical-record based analysis (UKCCS).
Int
J Cancer. 2024 Nov 13. doi:
10.1002/ijc.35166. PMID:
39535336. Observational study. ˍ
Monje M, Mahdi J, Majzner R, Yeom KW, Schultz LM, Richards RM,
Barsan V, Song KW, Kamens J, Baggott C, Kunicki M, Rietberg SP,
Lim AS, Reschke A, Mavroukakis S, Egeler E, Moon J, Patel S,
Chinnasamy H, Erickson C, Jacobs A, Duh AK, Tunuguntla R, Klysz
DD, Fowler C, Green S, Beebe B, Carr C, Fujimoto M, Brown AK,
Petersen AG, McIntyre C, Siddiqui A, Lepori-Bui N, Villar K, Pham
K, Bove R, Musa E, Reynolds WD, Kuo A, Prabhu S, Rasmussen L,
Cornell TT, Partap S, Fisher PG, Campen CJ, Grant G, Prolo L, Ye
X, Sahaf B, Davis KL, Feldman SA, Ramakrishna S, Mackall C.
Intravenous and intracranial GD2-CAR T
cells for H3K27M+
diffuse midline gliomas.
Nature.
2024 Nov 13. doi:
10.1038/s41586-024-08171-9. PMID:
39537919. Interventional study.
ˍ
Petitt JC, Murayi R, El-Abtah ME, Momin A, Halima A, Potter T,
Ahorukomeye P, Jarmula J, Thapliyal M, Murphy ES, Chao ST, Suh JH,
Recinos PF, Kshettry VR.
Outcomes of
adjuvant radiation treatment following subtotal resection of world
health organization grade II
meningiomas.
J
Neurooncol. 2024 Nov 13. doi:
10.1007/s11060-024-04878-x. PMID:
39538039. Observational study˰
ˍ
Hovman FR, Poulsen FR, Hansen S, Dahlrot RH.
The
risk of venous thromboembolism
in adult patients with diffuse glioma: a nationwide
population-based study.
Acta
Oncol. 2024 Nov 14;63:887-892. doi:
10.2340/1651-226X.2024.40137. PMID:
39543846. Observational study. ˍ
Tini P, Cinelli E, Yavorska M, Donnini F, Marampon F, Pastina P,
Rubino G, Chibbaro S, Cerase A, Mazzei MA, Di Giacomo AM, Minniti
G.
Serum lactate
dehydrogenase as a prognostic marker
for treatment response in IDH wild-type
glioblastoma patients undergoing
stupp protocol.
J
Neurooncol. 2024 Nov 14. doi:
10.1007/s11060-024-04862-5. PMID:
39540980. Observational study˰
ˍ
Atsukawa N, Tatekawa H, Ueda D, Oura T, Matsushita S, Horiuchi D,
Takita H, Mitsuyama Y, Baba R, Tsukamoto T, Shimono T, Miki Y.
Visualizing the association
between the location and prognosis of
isocitrate dehydrogenase wild-type
glioblastoma: a voxel-wise Cox
regression analysis with open-source datasets.
Neuroradiology.
2024 Nov 15. doi:
10.1007/s00234-024-03503-y. PMID:
39542911. Observational study˰
ˍ
Rafaelian AA, Martynov BV, Chemodakova KA, Kholyavin AI, Martynov
RS, Klimenkova EY, Prokudin MY, Papayan GV, Boykov IV, Svistov DV.
Stereotactic Photodynamic Therapy of
Recurrent Malignant Gliomas.
Sovrem
Tekhnologii Med. 2024 Apr 27;16(2):58-65. doi:
10.17691/stm2024.16.2.06. PMID:
39539750. Observational study. ˍ
Padilla H, Liu MD, Hass RM, Carabenciov ID, Mustafa R.
Primary
Diffuse Leptomeningeal Gliomatosis.
Neurohospitalist.
2024 Sep 27:19418744241289169. doi:
10.1177/19418744241289169. PMID:
39544271. Case report. ˍ
Fang Z, Shu T, Luo P, Shao Y, Lin L, Tu Z, Zhu X, Wu L.
The
peritumoral edema index and related mechanisms influence the
prognosis of GBM patients.
Front
Oncol. 2024 Oct 29;14:1417208. doi:
10.3389/fonc.2024.1417208. PMID:
39534094. Observational study. ˍ
Pepper NB, Prange NG, Troschel FM, Kröger K, Oertel M,
Kuhlmann T, Müther M, Grauer O, Stummer W, Eich HT.
Efficacy
and Low Toxicity of Normo-Fractionated Re-Irradiation with
Combined Chemotherapy for Recurrent Glioblastoma-An Analysis of
Treatment Response and Failure.
Cancers
(Basel). 2024 Oct 29;16(21):3652. doi:
10.3390/cancers16213652. PMID:
39518091. Observational study. ˍ
Rybka L, Jonkers R, Burzlaff M, Rosenstock T, Vajkoczy P, Picht T,
Faust K, Rofes A.
Preoperative
subjective impairments in language and memory in brain tumor
patients.
Front
Oncol. 2024 Oct 29;14:1475860. doi:
10.3389/fonc.2024.1475860. PMID:
39534098. Observational study. ˍ
Aboubechara JP, Aboud O.
Metabolic
Risk Factors and Survival in Patients with Glioblastoma.
Cancers
(Basel). 2024 Oct 30;16(21):3666. doi:
10.3390/cancers16213666. PMID:
39518104. Observational study. ˍ
Leonetti A, Puglisi G, Rossi M, Viganò L, Conti Nibali M,
Gay L, Sciortino T, Fornia L, Cerri G, Bello L.
Sexual
life in adults treated for brain tumors: a retrospective study.
Front
Oncol. 2024 Oct 30;14:1483697. doi:
10.3389/fonc.2024.1483697. PMID:
39540150. Observational study. ˍ
Song Y, Go KO.
Clinical Experiences
Using CyberKnife for Large-Volume Meningiomas: A Preliminary
Study.
Brain
Tumor Res Treat. 2024 Oct 31;12(4):230-236. doi:
10.14791/btrt.2024.0030. PMID:
39542519. Observational study. ˍ
Pehlivan UA, Aktekin EH, Yalcin C, Hasbay B, Gunesli A, Alkan O.
Diagnostic Utility of
Diffusion-Weighted Imaging in Distinguishing Common Pediatric
Posterior Fossa Tumors: A Single Center Retrospective Study.
Turk
Arch Pediatr. 2024 Nov 1;59(6):560-566. doi:
10.5152/TurkArchPediatr.2024.24154. PMID:
39540776. Observational study. ˍ
Li Y, Zheng Z, He Q.
Individualized
Prediction of Overall Survival Time for Patients with Primary
Intramedullary Spinal Cord Astrocytoma: A Population-Based Study.
World Neurosurg. 2024 Nov 5:S1878-8750(24)01796-0.
doi: 10.1016/j.wneu.2024.10.092. PMID:
39510174. Observational study˰
ˍ
Xie XP, Ganbold M, Li J, Lien M, Chipman ME, Wang T, Jayewickreme
CD, Pedraza AM, Bale T, Tabar V, Brennan C, Sun D, Sharma R,
Parada LF.
Glioblastoma functional
heterogeneity and enrichment of cancer stem cells with tumor
recurrence.
Neuron.
2024 Nov 6:S0896-6273(24)00733-5. doi:
10.1016/j.neuron.2024.10.012. PMID:
39510072. Laboratory investigation˰
ˍ
Reihanian Z, Abbaspour E, Zaresharifi N, Karimzadhagh S,
Mahmoudalinejad M, Sourati A, Farzin M, EslamiKenarsari H.
Impact
of Age and Gender on Survival of Glioblastoma Multiforme Patients:
A Multicenter Retrospective Study.
Cancer
Rep (Hoboken). 2024 Nov 7;7(11):e70050. doi:
10.1002/cnr2.70050. PMID:
39506810. Observational study. ˍ
Zeng M, Zheng M, Wang J, Li S, Ji N, Peng Y.
Effect
of perioperative dexmedetomidine on postoperative delirium in
patients with brain tumours: a protocol of a randomised controlled
trial.
BMJ
Open. 2024 Nov 7;14(11):e084380. doi:
10.1136/bmjopen-2024-084380. PMID:
39515867. Interventional study protocol. ˍ
Frosina G, Casella C, Puppo A, Marani E, Campanella D, Boni L,
Fontana V.
Epidemiology of malignant
brain tumors in Genova, Italy. 1993-2017.
Sci
Rep. 2024 Nov 8;14(1):27300. doi:
10.1038/s41598-024-79170-z. PMID:
39516674. Observational study. ˍ
Iwamoto FM, Tanguturi SK, Nayak L, Wang TJ, Desai A, Lustig RA,
Bagley S, Wong ET, Hertan LM, McCluskey C, Hayden J, Muzikansky A,
Nakhawa S, Japo J, Bossi CC, Meylan M, Tian Y, Barlow GL,
Speliakos P, Ayoub G, Meredith DM, Ligon KL, Haas-Kogan D, Huang
K, Wucherpfennig KW, Wen PY, Reardon DA.
Re-irradiation
plus pembrolizumab: Phase II study for recurrent glioblastoma
patients.
Clin
Cancer Res. 2024 Nov 8. doi:
10.1158/1078-0432.CCR-24-1629. PMID:
39513953. Interventional study˰
ˍ
Ning W, Qian X, Dunmall LC, Liu F, Guo Y, Li S, Song D, Liu D, Ma
L, Qu Y, Wang H, Gu C, Zhang M, Wang Y, Wang S, Zhang
H.
Non-secreting IL12 expressing
oncolytic adenovirus Ad-TD-nsIL12 in recurrent high-grade glioma:
a phase I trial.
Nat
Commun. 2024 Nov 8;15(1):9299. doi:
10.1038/s41467-024-53041-7. PMID:
39516192. Interventional study.
ˍ
Qiao X, Wang Z, Chen Y, Peng N, Zhang H, Niu C, Cheng C.
Combined
metformin and simvastatin therapy inhibits SREBP2 maturation and
alters energy metabolism in glioma.
Cell
Death Dis. 2024 Nov 9;15(11):809. doi:
10.1038/s41419-024-07169-5. PMID:
39521788. Laboratory investigation.
ˍ